While symptom resolution was not a significant outcome for any modality used within the timeframe and scope of this retrospective study, a clear trend was observed wherein patients with PPCS who received TAU+ILF experienced greater resolution of symptoms [TAU+ILF+CP (52%) and TAU+ILF-CP (50%)] compared to their cohorts who received TAU (38.5%) (see Table 4 ).
← all excerpts
Use of Novel Concussion Protocol With Infralow Frequency Neuromodulation Demonstrates Significant Treatment Response in Patients With Persistent Postconcussion Symptoms, a Retrospective Study.
1
—
—